Cargando…

Ceruloplasmin and Coronary Heart Disease—A Systematic Review

Several studies indicate that oxidative stress might play a central role in the initiation and maintenance of cardiovascular diseases. It remains unclear whether ceruloplasmin acts as a passive marker of inflammation or as a causal mediator. To better understand the impact of ceruloplasmin blood lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arenas de Larriva, Antonio P., Limia-Pérez, Laura, Alcalá-Díaz, Juan F., Alonso, Alvaro, López-Miranda, José, Delgado-Lista, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589051/ https://www.ncbi.nlm.nih.gov/pubmed/33096845 http://dx.doi.org/10.3390/nu12103219

Ejemplares similares

Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review
por: Torres-Peña, Jose D., et al.
Publicado: (2023)

Diet and SIRT1 Genotype Interact to Modulate Aging-Related Processes in Patients with Coronary Heart Disease: From the CORDIOPREV Study
por: Hidalgo-Moyano, Cristina, et al.
Publicado: (2022)

Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study
por: Martin-Piedra, Laura, et al.
Publicado: (2021)

Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2023)

Quality and Quantity of Protein Intake Influence Incidence of Type 2 Diabetes Mellitus in Coronary Heart Disease Patients: From the CORDIOPREV Study
por: de la Cruz-Ares, Silvia, et al.
Publicado: (2021)

Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021)

Influence of dietary intervention on microvascular endothelial function in coronary patients and atherothrombotic risk of recurrence
por: Millan-Orge, Marta, et al.
Publicado: (2021)

Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021)

Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023)

Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
por: Cano-Ibáñez, Naomi, et al.
Publicado: (2022)

Correction to: Long‑term effect of a dietary intervention with two‑healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
por: Cano-Ibáñez, Naomi, et al.
Publicado: (2022)

Coenzyme Q(10) Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases
por: Gutierrez-Mariscal, Francisco Miguel, et al.
Publicado: (2020)

A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2022)

A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
por: Rangel-Zuñiga, Oriol Alberto, et al.
Publicado: (2020)

Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
por: Mora-Ortiz, Marina, et al.
Publicado: (2022)

Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study
por: Jiménez-Lucena, Rosa, et al.
Publicado: (2018)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Hypertriglyceridemia Influences the Degree of Postprandial Lipemic Response in Patients with Metabolic Syndrome and Coronary Artery Disease: From the Cordioprev Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2014)

Mediterranean Diet and Endothelial Function: A Review of its Effects at Different Vascular Bed Levels
por: Torres-Peña, Jose D., et al.
Publicado: (2020)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2021)

“Sex and Ceruloplasmin Modulate the Response to Copper ...”
por: Tweedale, Tony
Publicado: (2005)

Ceruloplasmin and Copper: Méndez and Araya Respond
por: Méndez, Marco, et al.
Publicado: (2005)

Serum ceruloplasmin and the risk of cancer in Finland.
por: Knekt, P., et al.
Publicado: (1992)

Ceruloplasmin in Parkinson's disease and the nonmotor symptoms
por: Zhao, Xuemei, et al.
Publicado: (2018)

Ceruloplasmin Status in Medullary Thyroid Carcinoma
por: RAZAVI, Fatemeh, et al.
Publicado: (2020)

Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
por: Ryan, Fari, et al.
Publicado: (2019)

A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2021)

Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study)
por: Talavera-Garcia, Eva, et al.
Publicado: (2016)

Correction: Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study)
por: Talavera-Garcia, Eva, et al.
Publicado: (2016)

Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial
por: Yubero-Serrano, Elena M., et al.
Publicado: (2020)

Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin
Publicado: (1986)

Ceruloplasmin/Transferrin Ratio Changes in Alzheimer's Disease
por: Squitti, Rosanna, et al.
Publicado: (2010)

Serum Selenium and Ceruloplasmin in Nigerians with Peripartum Cardiomyopathy
por: Karaye, Kamilu M., et al.
Publicado: (2015)

Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
por: Wang, Bo, et al.
Publicado: (2019)

Production of Recombinant Human Ceruloplasmin: Improvements and Perspectives
por: Bonaccorsi di Patti, Maria Carmela, et al.
Publicado: (2021)

Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology
por: Liu, Zhidong, et al.
Publicado: (2022)

Ceruloplasmin and Iron Proteins in the Serum of Patients with Alzheimer's Disease
por: Torsdottir, Gudlaug, et al.
Publicado: (2011)

Salivary Ceruloplasmin Ferroxidase & Oxidase Activities in Celiac Patients
por: Hasan, Hathama R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hsourt2o45v3un1jeqd2unokpa